Four-dimensional computed tomography ventilation imaging-guided radiotherapy planning in different techniques for lung cancer - Scorecard - MDSpire

Four-dimensional computed tomography ventilation imaging-guided radiotherapy planning in different techniques for lung cancer

  • By

  • Shu-Qing Yang

  • Hui Yu

  • Yu-Long Yang

  • Cheng Wang

  • Yan Li

  • Di-Feng Guo

  • Chen-Shi Lin

  • Chao Li

  • Zhi-Qiang Cai

  • June 1, 2026

  • 0 min

Share

Clinical Scorecard: Utilizing Four-Dimensional Computed Tomography Ventilation Imaging for Radiotherapy Planning Techniques in Lung Cancer Management

At a Glance

CategoryDetail
Condition
Key Mechanisms
Target PopulationPatients with pathologically confirmed stage III-IV lung cancer, excluding those with prior chest RT or significant pulmonary abnormalities.
Care Setting

Key Highlights

  • highlight_1

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

      • Monitor radiation doses to functional lung and organs at risk, including specific dose limits.

      Risks

        Patient & Prescribing Data

        Eighteen patients with good performance status (KPS score ≥ 80), emphasizing the importance of performance status in treatment eligibility.

        Clinical Best Practices

        • best_practice_1
        • best_practice_2

        Related Resources & Content

        Original Source(s)

        Four-dimensional computed tomography ventilation imaging-guided radiotherapy planning in different techniques for lung cancer

        • by Shu-Qing Yang, Hui Yu, Yu-Long Yang, Cheng Wang, Yan Li, Di-Feng Guo, Chen-Shi Lin, Chao Li, Zhi-Qiang Cai

        • June 1, 2026

        Related Content

        Development of a CT-based comprehensive model with deep learning for differentiating pathological types of pulmonary ground-glass nodules

        An ASCO preview: What to watch for at cancer research’s big meeting

        Case report: complete pathologic response to neoadjuvant ensartinib in locally advanced, ALK-positive lung squamous cell carcinoma